Literature DB >> 1673026

Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

P A Clarke1, M Schwemmle, J Schickinger, K Hilse, M J Clemens.   

Abstract

Epstein-Barr virus encodes two small RNAs, EBER-1 and -2, that are abundantly expressed in latently infected cells. Recent evidence suggests a role for EBER-1 in regulation of translation since this RNA is able to prevent the inhibition of protein synthesis by double-stranded RNA in rabbit reticulocyte lysates. We show here that EBER-1 that has been synthesized in vitro forms a complex with the dsRNA-activated inhibitor of protein synthesis DAI, a protein kinase that specifically phosphorylates polypeptide chain initiation factor eIF-2. Gel retardation assays and UV crosslinking experiments indicate that complex formation is specific for EBER-1 and requires the presence of some secondary structure in the molecule. RNA competition studies show that EBER-1-DAI complex formation is not inhibited in the presence of other small RNA species, heparin or the synthetic double-stranded RNA, poly(I).poly(C). SDS gel analysis reveals the existence of two forms of the crosslinked complex, of 64-68kDa and 46-53kDa, both of which are recognized by anti-DAI antibodies in immunoprecipitation experiments. These data suggest that EBER-1 regulates protein synthesis through its ability to interact with DAI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673026      PMCID: PMC333586          DOI: 10.1093/nar/19.2.243

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.

Authors:  E Meurs; K Chong; J Galabru; N S Thomas; I M Kerr; B R Williams; A G Hovanessian
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

2.  Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function.

Authors:  K H Mellits; M Kostura; M B Mathews
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase.

Authors:  J Galabru; M G Katze; N Robert; A G Hovanessian
Journal:  Eur J Biochem       Date:  1989-01-02

6.  Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis.

Authors:  J Siekierka; T M Mariano; P A Reichel; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus.

Authors:  R A Bhat; B Thimmappaya
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

8.  Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs.

Authors:  E A Leibold; H N Munro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI.

Authors:  K H Mellits; M B Mathews
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity.

Authors:  M G Katze; D DeCorato; B Safer; J Galabru; A G Hovanessian
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  60 in total

1.  Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.

Authors:  I K Ruf; P W Rhyne; C Yang; J L Cleveland; J T Sample
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

3.  Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein.

Authors:  Gregory A Peters; David Khoo; Ian Mohr; Ganes C Sen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes.

Authors:  S Swaminathan; B S Huneycutt; C S Reiss; E Kieff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells.

Authors:  M Schwemmle; M J Clemens; K Hilse; K Pfeifer; H Tröster; W E Müller; M Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 6.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

Authors:  Mrinal Samanta; Dai Iwakiri; Teru Kanda; Tadaatsu Imaizumi; Kenzo Takada
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

8.  Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.

Authors:  Misako Yajima; Teru Kanda; Kenzo Takada
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 9.  Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

Authors:  C Sample; E Kieff
Journal:  Springer Semin Immunopathol       Date:  1991

10.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.